PartsTable
Technical Data Sheet
Download PDF

NDC00015-0549-41 — CYCLOPHOSPHAMIDE FOR INJECTION

✓ Government record, cited
— · COMPONENT
PRODUCT OVERVIEW

NDC00015-0549-41: CYCLOPHOSPHAMIDE FOR INJECTION.

The CYCLOPHOSPHAMIDE FOR INJECTION is a the manufacturer industrial component. Key specifications include physical_form: FREEZE-DRIED POWDER, features_provided: STERILE, primary_container_type: VIAL, protective_storage_feature: ANTINEOPLASTIC DRUG, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, warning_and_caution_statements: CHEMOTHERAPEUTIC AGENT; HANDLE WITH CARE. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-219-3900, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS
NDC00015-0549-41
NSN: 6505-01-219-3900
FSC: 6505 — Drugs and Biologicals
CAGE: 29398 — MEAD JOHNSON & COMPANY, LLC (USA)
SPECIFICATIONS
physical_formFREEZE-DRIED POWDER
features_providedSTERILE
primary_container_typeVIAL
protective_storage_featureANTINEOPLASTIC DRUG
medical_designation_and_gradeUNITED STATES PHARMACOPEIA
warning_and_caution_statementsCHEMOTHERAPEUTIC AGENT; HANDLE WITH CARE
total_primary_container_quantity6
primary_container_content_quantity2.000 GRAMS OF ACTIVE INGREDIENT G
active_medicament_medicinal_strength2.000 GRAMS CYCLOPHOSPHAMIDE ACTIVE INGREDIENT G
part_name_assigned_by_controlling_agencyCYCLOPHOSPHAMIDE FOR INJECTION USP 2GM VIAL FREEZE DRIED POWDER 6S
NSN6505-01-219-3900
COMPONENT DIAGRAM
COMPONENT MAIN IC EDGE CONNECTOR No detailed specs available CYCLOPHOSPHAMIDE FOR INJECTION TITLE COMPONENT PN NDC00015-0549-41 MFR CYCLOPHOSPHAMIDE FOR I
KEY FEATURES
•
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 GRAMS OF ACTIVE INGREDIENT G
•
MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA
•
FEATURES PROVIDED: STERILE
•
PRIMARY CONTAINER TYPE: VIAL
•
PHYSICAL FORM: FREEZE-DRIED POWDER
•
PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG
•
WARNING AND CAUTION STATEMENTS: CHEMOTHERAPEUTIC AGENT; HANDLE WITH CARE
TECHNICAL CHARACTERISTICS
PRIMARY CONTAINER CONTENT QUANTITY2.000 GRAMS OF ACTIVE INGREDIENT G
MEDICAL DESIGNATION AND GRADEUNITED STATES PHARMACOPEIA
FEATURES PROVIDEDSTERILE
PRIMARY CONTAINER TYPEVIAL
PHYSICAL FORMFREEZE-DRIED POWDER
PROTECTIVE STORAGE FEATUREANTINEOPLASTIC DRUG
PART NAME ASSIGNED BY CONTROLLING AGENCYCYCLOPHOSPHAMIDE FOR INJECTION USP 2GM VIAL FREEZE DRIED POWDER 6S
WARNING AND CAUTION STATEMENTSCHEMOTHERAPEUTIC AGENT; HANDLE WITH CARE
ACTIVE MEDICAMENT MEDICINAL STRENGTH2.000 GRAMS CYCLOPHOSPHAMIDE ACTIVE INGREDIENT G
TOTAL PRIMARY CONTAINER QUANTITY6
SUBSTITUTES & CROSS-REFERENCES 1
CYTOXANReference document
Same NSN cross-reference
Reference document — Secondary reference
LIFECYCLE
NSN statusActive· U.S. Government catalog
Shelf-life managedAcquisition advice: Terminal item — stock exhausted; no further procurementNo demilitarization required
Ready to buy NDC00015-0549-41?
Compare prices from verified sellers on eBay
Buy on eBay →
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is NDC00015-0549-41?
NDC00015-0549-41 is a CYCLOPHOSPHAMIDE FOR INJECTION.
What parts can replace NDC00015-0549-41?
There is 1 known substitute for NDC00015-0549-41: CYTOXAN. Substitute compatibility should be verified for your specific system.
What is the NSN for NDC00015-0549-41?
NDC00015-0549-41 is cataloged in the U.S. Government catalog under NSN 6505-01-219-3900. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.

Request a Quote — NDC00015-0549-41